ABCL

#2044
AbCellera Biologics Inc. Common Shares
3.61
+3.74%
부문:
베이스:
수익 통화:
일일 변동 비율
3.61
3.61
년간 변동
1.89
6.52
일일 변동
+3.74%
월간 변동
-10.86%
6달 변화
-18.51%
년간 변동율
+32.72%
이전 종가
3.48
Open
3.61
Bid
Ask
Low
3.61
High
3.61
양
47
Open full chart

Financials

Overview 성명 Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value 20212022202320242025 TTM

AbCellera Biologics Inc

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

뉴스